vVardis stock drops 7% in NYSE debut after $175M IPO
Shares of Zug-based dental health firm vVardis fell 7% in their NYSE debut Friday after raising $175 million in an IPO priced below its marketed range. The company sold 9.7 million shares at $18 each, vs. $21–$24.
This is HUB News’s original summary. Read the complete report at New York Post.